Rapid Determination in the Quality Control of Chinese Patent Medicine

被引:1
|
作者
Lu, Shao Hua [1 ]
Zhang, Ming Cai [1 ]
Zhai, Hong Lin [1 ]
Bi, Ke Xin [1 ]
Zhao, Bing Qiang [1 ]
机构
[1] Lanzhou Univ, Coll Chem & Chem Engn, Lanzhou 730000, Peoples R China
关键词
Multiple target components; Quantitative analysis; HPLC-DAD; Tchebichef moments; Quality control; QUANTITATIVE-ANALYSIS; IMAGE;
D O I
10.1007/s12247-021-09608-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose Due to the large number of chemical components in Chinese patent medicine, the quality control analysis is faced with greater challenges. Although different detection techniques, analytical conditions, and sample pretreatments are often employed respectively to quantify the multiple target components in complex mixtures, it is difficult to meet the practical requirement of productive enterprises. Methods Tchebichef moments (TMs) were calculated from the raw HPLC-DAD spectra of samples and the linear quantitative models were established by stepwise regression for the eight active components (four alkaloids, one statin, and three glycosides) in Daizongfang (one kind of Chinese patent medicines), respectively. Results The correlation coefficients of prediction (R-p(2)) were higher than 0.9159, and the spiked recovery rates were from 93.4 to 108.2%. Compared with the N-PLS and MCR-ALS models, the TM models are more accurate and reliable. Conclusions This study not only indicates that chemometrics approach has outstanding advantages for the identification of complex signal, but also provides another way for the rapid analysis of quality control in production.
引用
收藏
页码:1305 / 1313
页数:9
相关论文
共 50 条
  • [1] Rapid Determination in the Quality Control of Chinese Patent Medicine
    Shao Hua Lu
    Ming Cai Zhang
    Hong Lin Zhai
    Ke Xin Bi
    Bing Qiang Zhao
    Journal of Pharmaceutical Innovation, 2022, 17 : 1305 - 1313
  • [2] On the quality assessment of Chinese patent medicine
    Xie, PS
    Yan, YZ
    DRUG DISCOVERY AND TRADITIONAL CHINESE MEDICINE: SCIENCE, REGULATION, AND GLOBALIZATION, 2001, : 125 - 136
  • [3] Rapid Determination of Rutin Content in Chinese Patent Medicine Qi Ming Granules by RP-HPLC.
    Han, Ning
    Yu, Li
    Zhu, Dasheng
    Wu, Yazhen
    BIOMEDICAL RESEARCH-INDIA, 2015, 26 (01): : 157 - 160
  • [4] Quality Control for Traditional Medicines–Chinese Patent Medicines
    马双成
    WorldJournalofIntegratedTraditionalandWesternMedicine, 2019, 5 (04) : 28 - 31
  • [5] Chinese patent medicine Tongxinluo: A review on chemical constituents, pharmacological activities, quality control, and clinical applications
    Chen, Qin
    Zou, Junbo
    Shi, Yajun
    Zhang, Xiaofei
    Guo, Dongyan
    Luan, Fei
    Sun, Jing
    PHYTOMEDICINE, 2024, 132
  • [6] Quality control of Chinese patent medicine flavonol glycoside in Ginkgo biolba extract with micellar, electrokinetic capillary chromatography
    Deng, YZ
    Yuan, DX
    Jin, XY
    Lin, QM
    CHINESE JOURNAL OF ANALYTICAL CHEMISTRY, 2003, 31 (05) : 580 - 583
  • [7] Quality Evaluation and Quality Control of Botanicals and Traditional Chinese Medicine
    Luo, G. A.
    Liang, Q. L.
    Yang, H. H.
    Wang, Y. M.
    PLANTA MEDICA, 2009, 75 (04) : 405 - 405
  • [8] An Empirical Study on the Patent Quality of Chinese Herbal Medicine Geographical Indications Industry
    Sun, Zhi
    Feng, Guifeng
    Qiao, Yongzhong
    PROCEEDINGS OF THE 2ND INTERNATIONAL CONFERENCE ON JUDICIAL, ADMINISTRATIVE AND HUMANITARIAN PROBLEMS OF STATE STRUCTURES AND ECONOMIC SUBJECTS (JAHP 2017), 2017, 159 : 150 - 154
  • [9] EXTERNAL USE OF CHINESE PATENT MEDICINE
    Li, Yan
    Song, Yagang
    Miao, Mingsan
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 80 (01) : 15 - 15
  • [10] Study on Chinese patent medicine based on major component analysis and quality control evaluation: A case study of Jizhi Syrup
    Ding, Haoran
    Liu, Feng
    Wang, Mengyue
    Dong, Bangjian
    Li, Xiaobo
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2022, 209